Immunohistochemical staining, laser capture microdissection, and filter-aided sample preparation-assisted proteomic

Jintang He1, Jianhui Zhu, Yashu Liu

  • 1Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI 48109-0656, USA.

Electrophoresis
|February 26, 2013
PubMed

Insights

A new method, ILFAPT, isolates specific cell populations from tissue for proteomic analysis. This technique successfully identified proteins in rare glioblastoma stem-like cells, advancing cell-specific research.

Area of Science:

  • Proteomics
  • Cell Biology
  • Cancer Research

Background:

  • Isolating specific cell subpopulations from clinical tissues for proteomic study is challenging.
  • Existing methods often lack the sensitivity to analyze small cell quantities.
  • Understanding cell-specific protein expression is crucial for disease research.

Purpose of the Study:

  • To develop and validate a novel method for isolating and analyzing proteomes of specific target cell populations within tissue samples.
  • To demonstrate the application of this method for analyzing rare stem-like cells in glioblastoma multiforme.

Main Methods:

  • Immunohistochemical staining to highlight target cells.
  • Laser capture microdissection (LCM) to isolate cells.
  • Filter-aided sample preparation (FASP) for proteomic analysis.
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) for protein identification and quantification.

Main Results:

  • The ILFAPT method successfully isolated CD90(+) stem-like cells from glioblastoma multiforme tissue.
  • 674 high-confidence proteins were identified from a small volume (32 nL) of isolated cells.
  • 109 differentially expressed proteins were quantified between CD90(+) and CD90(-) cells, primarily related to cell adhesion and movement.

Conclusions:

  • The ILFAPT method enables in-depth proteome analysis of very small, specific cell populations within complex tissue specimens.
  • This technique has broad applicability for studying target cell populations in clinical samples.
  • ILFAPT advances the capability for cell-specific proteomic research in oncology and beyond.